TD Waterhouse Canada’s Emergent Biosolutions EBS Stock Holding History

TD Waterhouse Canada’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-125	Closed	-$1.15K	–	2080
2025 Q3	$1.15K	Hold	125	–	–	﹤0.01%	1883
2025 Q2	$823	Hold	125	–	–	﹤0.01%	1823
2025 Q1	$590	Sell	125 -65	-34%	-$538	﹤0.01%	1785
2024 Q4	$1.81K	Hold	190	–	–	﹤0.01%	1715
2024 Q3	$1.6K	Hold	190	–	–	﹤0.01%	1654
2024 Q2	$1.35K	Buy	+190	New	+$818	﹤0.01%	1702
2024 Q1	–	Sell	-65	Closed	-$205	–	1810
2023 Q4	$205	Hold	65	–	–	﹤0.01%	1632
2023 Q3	$281	Hold	65	–	–	﹤0.01%	1631
2023 Q2	$648	Hold	65	–	–	﹤0.01%	1634
2023 Q1	$855	Hold	65	–	–	﹤0.01%	1611
2022 Q4	$1.07K	Hold	65	–	–	﹤0.01%	1553
2022 Q3	$1.87K	Hold	65	–	–	﹤0.01%	1511
2022 Q2	$2.67K	Buy	+65	New	+$2.22K	﹤0.01%	1503

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TD Waterhouse Canada's EBS Position: Q4 2025 in Review

TD Waterhouse Canada sold out of Emergent Biosolutions (EBS) in Q4 2025, closing a stake of 125 shares — an estimated $1.15K sold.

TD Waterhouse Canada first reported a position in EBS in Q2 2022 and held it in 13 quarters. The position peaked at $2.67K in Q2 2022. 183 funds tracked by Wall St. Rank hold EBS as of Q4 2025.

TD Waterhouse Canada reported no remaining Emergent Biosolutions position as of Q4 2025 after selling out during the quarter.
TD Waterhouse Canada sold 125 Emergent Biosolutions shares in Q4 2025, an estimated $1.15K.
TD Waterhouse Canada first reported a position in Emergent Biosolutions in Q2 2022 and held it in 13 quarters.
TD Waterhouse Canada's Emergent Biosolutions position peaked at $2.67K in Q2 2022.
183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2025.

Based on TD Waterhouse Canada's 13F filing for Q4 2025, filed 27 Jan 2026.